TorreyPinesInv

Torrey Pines Investment - a specialty life-science investment company, specializing in early development stage assets from international pharma and biotech.

[TorreyPinesInv @TorreyPinesInv]

Great comparison of the currently approved oral antivirals for #COVID19 by @ViriomInc. @MDPIOpenAccess

[Viriom @ViriomInc]

We've analyzed the risk/benefit profiles of the three leading oral antivirals for treatment of COVID-19 and here is what we found:
https://t.co/fbRh2UhP4y #covid19pandemic #covid #covid19research #covid19solutions #antivirals

[TorreyPinesInv @TorreyPinesInv]

Happy to be working alongside @OrbiMed and i2020 Accelerator to to help bring novel targeted treatments for cancer, immunological and neurodegenerative diseases! https://t.co/1n3YFUVqmv #Biotechnology #startups #cancer #treatment #LifeSciences #LifeSciencesNews

[i2020accelerator @i2020accelerat1]

Happy to announce additional financing for our breakthrough Cancer-, Inflammation- and Neurology-focused therapeutics together with @OrbiMed! Learn more
https://t.co/0z7McltyGv #startup #accelerator #LifeSciences #Cancer #Investment #neurology

[TorreyPinesInv @TorreyPinesInv]

Avifavir has shown early and statistically significant differentiation compared to Standard of Supportive Care for #COVID19, with a 33% faster virological response, 20% shorter time to normalized clinical symptoms; and 31% lower mortality rate. https://t.co/iX5fJCYYlc

[TorreyPinesInv @TorreyPinesInv]

Great news from @i2020accelerat1 - all programs will be supported by the #ArtificialIntelligence and computer aided drug design platform of @MolSoft from San Diego, CA and other research partners from i2020 Accelerator's network. A truly global collaboration! #CancerResearch

[i2020accelerator @i2020accelerat1]

Happy to announce that together with @OrbiMed we will invest $28.5M in breakthrough #cancer programs of 4 innovative companies! Learn more https://t.co/CaTPVyX65l

[TorreyPinesInv @TorreyPinesInv]

Great news from @ViriomInc - they are initiating a Phase 2a study investigating the efficacy of an intramuscular long-acting injectable nanoformulation of VM1500A in HIV-infected patients. The results of the Phase 1 study have been presented at CROI 2020 in Boston. #HIV

[Viriom @ViriomInc]

Excited to start exploring the potential of delivering therapeutic doses of VM1500A over 4 and 8-week periods! #hiv #treatment #antiviral #clinicaltrials #phase2 #clinicalresearch #drugdevelopment https://t.co/18wfYF5Ig4

[TorreyPinesInv @TorreyPinesInv]

@Viriom is working with global health authorities to determine the efficacy and safety of Elpida and its other clinical candidates AV5080, AV5124 and AV5126 against #COVID19 - https://t.co/1J0uZ2jN6f…/17816949-viriom-donates-elpida-t…
#coronavirus #treatment #china #russia

[TorreyPinesInv @TorreyPinesInv]

Meet Viriom at CROI 2020 in Boston this March! #boston2020 #conference #virus #hiv #treatment #phase1 https://t.co/BTS3sojCfG

[TorreyPinesInv @TorreyPinesInv]

@Viriom is launching reproductive toxicity studies of Elpida®, supported by DAIDS (NIH) https://t.co/asbiAvPKsy #hiv #hivaids #toxicity #nih #treatment #preclinical

[i2020accelerator @i2020accelerat1]

Excited to help advance development of novel #neuroprotectants and non-addictive #pain #treatments with high specificity alongside @TorreyPinesInv, @ChemDiv and University of Turku! https://t.co/FwV8KzuoSy #Neurology #Science #research #drugs #treatment

[TorreyPinesInv @TorreyPinesInv]

@i2020accelerat1 has plenty to share when it comes to effective management of investment, business planning and partnering opportunities in the life science industry - meet them in Stockholm!

[i2020accelerator @i2020accelerat1]

Meet us at #LSXNORDIC this August in #Stockholm!

[TorreyPinesInv @TorreyPinesInv]

A once weekly oral administration of medicines could really simplify HIV treatment regimen for millions of people worldwide. #HIV #AIDSfree

[TorreyPinesInv @TorreyPinesInv]

Potential once monthly or once quarterly dosing for HIV treatment and prevention from @Viriom.

[TorreyPinesInv @TorreyPinesInv]

Potential once monthly or once quarterly dosing for HIV treatment and prevention from @Viriom.

[Viriom @ViriomInc]

Viriom Initiates Phase 1 Clinical Trial of Once Monthly Injectable HIV Treatment #clinicaltrials #clinicaltrial #phase #HIV #AIDS https://t.co/iFtzdhbJOG

[TorreyPinesInv @TorreyPinesInv]

Excited to welcome @SnapBioSci into our i2020 Accelerator investment framework and Help Advance their Selective Kinase Inhibitor Platform for Treatment of Endodermal Cancers and Autoimmune Diseases - https://t.co/9CWaKtZRGt #Cancer #autoimmunedisease #Collaboration

[TorreyPinesInv @TorreyPinesInv]

Excited about our new partnership with @19_labs, creator of innovative #telehealth 2.0 point of care solutions. https://t.co/hJidu0JSvw #Healthcare #homecare

[TorreyPinesInv @TorreyPinesInv]

Torrey Pines Invests in @19_Labs’ Innovative Telehealth 2.0 Point of Care Solutions #healthcare #telehealth https://t.co/35mC47x0XK

[TorreyPinesInv @TorreyPinesInv]

Does chronotherapy work? #therapy #DRUGS #circadianclock https://t.co/kLCY2Gi1CN

[Corie Lok @CorieLok]

"Research suggests that the majority of today’s best-selling drugs, including heartburn medications and treatments for erectile dysfunction, work better when taken at specific times of day. " https://t.co/Y5rKOjvgfa

[TorreyPinesInv @TorreyPinesInv]

What we should all be prepared for. https://t.co/oXYSe6mU1f

[TorreyPinesInv @TorreyPinesInv]

@SquarespaceHelp Our case has been assigned to 3 already, and they all have sent us the same guide over and over again. You guys should really get a helpline with people who can provide personalized help rather than just send you a "one-size-fits-all" type of a guide.

[TorreyPinesInv @TorreyPinesInv]

@squarespace your "24/7" customer support that will respond "in under an hour" seems to be a joke. soon 2 weeks back&forth trying to connect an existing domain, 24+ hours each time trying to get a response to an email. #CustomerExperience goes down the drain